緩釋性輔料市場規模、佔有率及成長分析（按類型、技術、給藥途徑及地區）- 產業預測 2025-2032

緩釋緩釋性市場規模預計在 2023 年達到 16 億美元，並從 2024 年的 17.3 億美元成長到 2032 年的 32.3 億美元，預測期內（2025-2032 年）的複合年成長率為 8.1%。

受慢性病發病率上升和對創新藥物輸送系統的需求增加的推動，全球緩釋性輔料市場正在經歷強勁成長。緩釋性製劑能逐漸釋放藥物，提高病患的遵從性和治療效果，輔料已成為各種劑型中不可或缺的。賦形劑技術的最新進展，包括新型聚合物和塗層，正在擴大可用的配方選擇。從跨國公司到專業公司，主要企業都在積極投資研究並建立夥伴關係來生產定製配方。雖然北美和歐洲引領市場，但亞太和拉丁美洲等新興地區也正在迅速擴張。隨著對精準醫療和個人化治療的關注，以及對複雜輔料解決方案的需求增加，未來前景光明。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究

緩釋性輔料市場規模（按類型和複合年成長率） （2025-2032）

• 市場概況
• 明膠
• 聚合物
• 礦物
• 糖
• 其他

緩釋性輔料市場規模（依技術及複合年成長率） (2025-2032)

• 市場概況
• 定向投放
• 微囊化
• 沃斯特技術
• 其他

緩釋性輔料市場規模（依給藥途徑及複合年成長率） (2025-2032)

• 市場概況
• 口服
• 肌肉注射
• 皮下
• 經皮
• 靜脈
• 其他

緩釋性輔料市場規模（依地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• International Flavors & Fragrances Inc.（United States）
• Evonik Industries AG（Germany）
• BASF SE（Germany）
• Kerry Group Plc（Ireland）
• Roquette Freres（France）
• Merck KGaA（Germany）
• Associated British Foods Plc（United Kingdom）
• ADM（United States）
• Wacker Chemie AG（Germany）
• Croda International Plc（United Kingdom）
• Gattefosse（France）
• Colorcon Inc.（United States）
• AstraZeneca PLC（United Kingdom）
• GlaxoSmithKline PLC（United Kingdom）
• Mayne Pharma Group Limited（Australia）
• Sun Pharmaceutical Industries Ltd.（India）
• Pfizer Inc.（United States）
• Novartis AG（Switzerland）

結論和建議

Sustained Release Excipients Market size was valued at USD 1.6 billion in 2023 and is poised to grow from USD 1.73 billion in 2024 to USD 3.23 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global sustained release excipients market is experiencing robust growth, fueled by a rising prevalence of chronic diseases and an increased demand for innovative drug delivery systems. As sustained release formulations facilitate gradual drug release, they enhance patient compliance and therapeutic effectiveness, making their excipients vital in various dosage forms. Recent advancements in excipient technologies, including novel polymers and coatings, broaden the formulation options available. Key players, ranging from multinational firms to specialized companies, are actively investing in research and forging partnerships to create customized formulations. While North America and Europe lead the market, emerging regions like Asia-Pacific and Latin America are also expanding rapidly. The future looks bright, with a focus on precision medicine and personalized therapies driving demand for sophisticated excipient solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sustained Release Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sustained Release Excipients Market Segments Analysis

Global Sustained Release Excipients Market is segmented by Type, Technology, Route of Administration and region. Based on Type, the market is segmented into Gelatin, Polymers, Minerals, Sugars and Others. Based on Technology, the market is segmented into Targeted Delivery, Microencapsulation, Wurster Technique and Others. Based on Route of Administration, the market is segmented into Oral, Intramuscular, Subcutaneous, Transdermal, Intravenous and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sustained Release Excipients Market

The Sustained Release Excipients market is significantly influenced by the aging global population, which is reshaping demographic trends and leading to increased demand for healthcare products and pharmaceuticals. These excipients offer notable advantages, including prolonged drug release, which enhances patient compliance and is particularly beneficial for managing chronic conditions prevalent among elderly individuals. As healthcare providers seek to address the unique challenges posed by this demographic shift, the necessity for medications tailored to the needs of older patients becomes increasingly apparent. Consequently, this trend is expected to sustain a consistent demand for sustained release excipients within the pharmaceutical industry.

Restraints in the Sustained Release Excipients Market

The Sustained Release Excipients market faces significant constraints due to stringent regulations that govern drug approval and release within the pharmaceutical industry. This complex regulatory framework presents substantial challenges, as companies must navigate lengthy approval processes while ensuring compliance, resulting in high costs and time commitments. Additionally, frequent updates to regulatory standards and guidelines can lead to unforeseen delays in product development and market launch. Such obstacles not only impede the timely introduction of new products but also hinder overall market growth, making it crucial for companies to carefully manage their approaches to meet these requirements effectively.

Market Trends of the Sustained Release Excipients Market

The Sustained Release Excipients market is witnessing a significant trend towards increased focus on personalized medicine, propelled by advancements in biomarker identification and genomics. As the pharmaceutical industry pivots towards tailored therapeutics that cater to individual patient profiles, the demand for sustained release excipients is escalating. These excipients facilitate precise dosing and optimized timing of drug release, enhancing therapeutic outcomes while reducing side effects. This trend aligns with the broader shift towards patient-centric healthcare and is fostering innovation in excipient formulations and technologies, ultimately supporting the development of more effective and personalized drug delivery systems.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Sustained Release Excipients Market Size by Type & CAGR (2025-2032)

• Market Overview
• Gelatin
• Polymers
• Minerals
• Sugars
• Others

Global Sustained Release Excipients Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Targeted Delivery
• Microencapsulation
• Wurster Technique
• Others

Global Sustained Release Excipients Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Intramuscular
• Subcutaneous
• Transdermal
• Intravenous
• Others

Global Sustained Release Excipients Market Size & CAGR (2025-2032)

• North America (Type, Technology, Route of Administration)
  • US
  • Canada
• Europe (Type, Technology, Route of Administration)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Route of Administration)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Route of Administration)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Route of Administration)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• International Flavors & Fragrances Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croda International Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gattefosse (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayne Pharma Group Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations